Product
IDOV-SAFE
1 clinical trial
1 indication
Clinical trial
An Open Label, Dose-escalation and Extension, Phase I Clinical Study on Evaluating Safety, Tolerability and Pharmacodynamics of Intravenous Administration of IDOV-SAFE in Patients With Advanced Malignant Solid Tumors Who Have Failed in Standard Treatment.Status: Recruiting, Estimated PCD: 2025-11-30